Embedding a Linkage to Preexposure Prophylaxis Care Intervention in Social Network Strategy and Partner Notification Services: Results From a Pilot Randomized Controlled Trial.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
01 02 2021
Historique:
received: 19 05 2020
accepted: 23 09 2020
pubmed: 29 10 2020
medline: 6 8 2021
entrez: 28 10 2020
Statut: ppublish

Résumé

Increased preexposure prophylaxis (PrEP) uptake among black men who have sex with men and black transgender women (BMSM/TW) is needed to end the HIV epidemic. Embedding a brief intervention in network services that engage individuals in HIV transmission networks for HIV/ sexually transmitted infections testing may be an important strategy to accelerate PrEP uptake. Partner Services PrEP study is a pilot, randomized, control trial to improve linkage to PrEP care among BMSM/TW presenting for network services in Chicago, IL, from 2015 to 2017. BMSM/TW (N = 146) aged 18-40 years were recruited from network services (partners services and social network strategy services). Intervention participants developed an individualized linkage plan based on the information-motivation-behavioral skills model and received minibooster sessions. Control participants received treatment as usual. Sociodemographic, behavioral, and clinical factors were examined at baseline and 3- and 12-month postintervention. Intent-to-treat analyses examined linkage to PrEP care within 3-month postintervention (primary outcome). Secondary outcomes were PrEP initiation, time to linkage to PrEP care, and time to PrEP initiation. Compared with control participants, a significantly greater proportion of the intervention participants were linked to PrEP care within 3 months (24% vs. 11%; P = 0.04) and initiated PrEP (24% vs. 11%; P = 0.05). Among those linked to PrEP care within the study period, intervention participants were linked significantly sooner than control participants [median (interquartile range) days, 26.5 (6.0-141.8) vs. 191.5 (21.5-297.0); P = 0.05]. Study results support the preliminary efficacy of Partner Services PrEP to improve linkage to PrEP care and PrEP initiation among BMSM/TW.

Sections du résumé

BACKGROUND
Increased preexposure prophylaxis (PrEP) uptake among black men who have sex with men and black transgender women (BMSM/TW) is needed to end the HIV epidemic. Embedding a brief intervention in network services that engage individuals in HIV transmission networks for HIV/ sexually transmitted infections testing may be an important strategy to accelerate PrEP uptake.
SETTING
Partner Services PrEP study is a pilot, randomized, control trial to improve linkage to PrEP care among BMSM/TW presenting for network services in Chicago, IL, from 2015 to 2017.
METHODS
BMSM/TW (N = 146) aged 18-40 years were recruited from network services (partners services and social network strategy services). Intervention participants developed an individualized linkage plan based on the information-motivation-behavioral skills model and received minibooster sessions. Control participants received treatment as usual. Sociodemographic, behavioral, and clinical factors were examined at baseline and 3- and 12-month postintervention. Intent-to-treat analyses examined linkage to PrEP care within 3-month postintervention (primary outcome). Secondary outcomes were PrEP initiation, time to linkage to PrEP care, and time to PrEP initiation.
RESULTS
Compared with control participants, a significantly greater proportion of the intervention participants were linked to PrEP care within 3 months (24% vs. 11%; P = 0.04) and initiated PrEP (24% vs. 11%; P = 0.05). Among those linked to PrEP care within the study period, intervention participants were linked significantly sooner than control participants [median (interquartile range) days, 26.5 (6.0-141.8) vs. 191.5 (21.5-297.0); P = 0.05].
CONCLUSION
Study results support the preliminary efficacy of Partner Services PrEP to improve linkage to PrEP care and PrEP initiation among BMSM/TW.

Identifiants

pubmed: 33109935
pii: 00126334-202102010-00010
doi: 10.1097/QAI.0000000000002548
pmc: PMC8103968
mid: NIHMS1690443
doi:

Substances chimiques

Anti-HIV Agents 0

Banques de données

ClinicalTrials.gov
['NCT02749955']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-199

Subventions

Organisme : NIMH NIH HHS
ID : R34 MH104058
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH121187
Pays : United States
Organisme : NHLBI NIH HHS
ID : K12 HL143959
Pays : United States
Organisme : NIDA NIH HHS
ID : R25 DA028567
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI117943
Pays : United States

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

Centers for Disease Control and Prevention: US Public Health Service: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update: A Clinical Practice Guideline. Washington D.C: US Public Health Service; 2018. Available at: https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf .
Centers for Disease Control and Prevention. NCHHSTP AtlasPlus. 2019. Availabel at: https://www.cdc.gov/nchhstp/atlas/index.htm . Accessed on May 5, 2020.
Becasen JS, Denard CL, Mullins MM, et al. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. Am J Public Health. 2019;109:e1–e8.
Ward LM, Bruce MA, Thorpe RJ Jr, et al. Correlates associated with willingness to start pre-exposure prophylaxis Among young black men who have sex with men (MSM) in jackson, Mississippi. Fam Commun Health. 2019;42:189–196.
Rolle CP, Rosenberg ES, Luisi N, et al. Willingness to use pre-exposure prophylaxis among Black and White men who have sex with men in Atlanta, Georgia. Int J STD AIDS 2017;28:849–857.
Hoots BE, Finlayson T, Nerlander L, et al.; National HIVBSSG. Willingness to take, use of, and indications for pre-exposure prophylaxis Among men who have sex with men-20 US cities, 2014. Clin Infect Dis. 2016;63:672–677.
Poteat T, Wirtz A, Malik M, et al. A gap between willingness and uptake: findings from mixed methods research on HIV prevention among black and latina transgender women. J Acquir Immune Defic Syndr. 2019;82:131–140.
Marcus JL, Hurley LB, Hare CB, et al. Disparities in uptake of HIV preexposure prophylaxis in a large integrated health care system. Am J Public Health. 2016;106:e2–e3.
Kuhns LM, Hotton AL, Schneider J, et al. Use of pre-exposure prophylaxis (PrEP) in young men who have sex with men is associated with race, sexual risk behavior and peer network size. AIDS Behav. 2017;21:1376–1382.
Eaton LA, Matthews DD, Driffin DD, et al. A multi-US city assessment of awareness and uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among black men and transgender women who have sex with men. Prev Sci. 2017;18:505–516.
Harris NS, Johnson AS, Huang YA, et al. Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis—United States, 2013-2018. MMWR Morb Mortal Wkly Rep. 2019;68:1117–1123.
Goedel WC, King MRF, Lurie MN, et al. Effect of racial inequities in pre-exposure prophylaxis use on racial disparities in HIV incidence among men who have sex with men: a modeling study. J Acquir Immune Defic Syndr. 2018;79:323–329.
Ezennia O, Geter A, Smith DK. The PrEP care Continuum and black men who have sex with men: a scoping review of published data on awareness, uptake, adherence, and retention in PrEP care. AIDS Behav. 2019;23:2654–2673.
Department of Health and Human Services. (Feb 5, 2019) Ending the HIV Epidemic: A Plan for America [press Release]. Available at: https://www.hhs.gov/blog/2019/02/05/ending-the-hiv-epidemic-a-plan-for-america.html . October 24, 2019.
Schneider JA, Bouris A, Smith DK. Race and the public health impact potential of pre-exposure prophylaxis in the United States. J Acquir Immune Defic Syndr. 2015;70:e30–32.
Remy L, Enriquez M. Behavioral interventions to enhance PrEP uptake among black men who have sex with men: a review. J Assoc Nurses AIDS Care. 2019;30:151–163.
Mayer KH, Safren SA, Elsesser SA, et al. Optimizing pre-exposure antiretroviral prophylaxis Adherence in men who have sex with men: results of a pilot randomized controlled trial of life-steps for PrEP. AIDS Behav. 2017;21:1350–1360.
Wheeler DP, Fields SD, Beauchamp G, et al. Pre-exposure prophylaxis initiation and adherence among Black men who have sex with men (MSM) in three US cities: results from the HPTN 073 study. J Int AIDS Soc. 2019;22:e25223.
Valente TW. Network interventions. Science. 2012;337:49–53.
Rao S, Song W, Mulatu M, et al. HIV partner service delivery among blacks or African Americans—United States, 2016. MMWR. 2019;68:81–86.
McCree DH, Millett G, Baytop C, et al. Lessons learned from use of social network strategy in HIV testing programs targeting African American men who have sex with men. Am J Public Health. 2013;103:1851–1856.
Katz DA, Dombrowski JC, Barry M, et al. STD partner services to monitor and promote HIV pre-exposure prophylaxis use among men who have sex with men. J Acquir Immune Defic Syndr. 2019;80:533–541.
Myers JE, Edelstein ZR, Daskalakis DC, et al. Preexposure prophylaxis monitoring in New York city: a public health approach. Am J Public Health. 2018;108:S251–S257.
Bhatia R, Modali L, Lowther M, et al. Outcomes of preexposure prophylaxis referrals from public STI clinics and implications for the preexposure prophylaxis Continuum. Sex Transm Dis. 2018;45:50–55.
Kimbrough LW, Fisher HE, Jones KT, et al. Accessing social networks with high rates of undiagnosed HIV infection: the social networks demonstration project. Am J Public Health. 2009;99:1093–1099.
Emerson C, Brown T, Illemsky S, et al. Use of social networks to identify persons with undiagnosed HIV infection—seven U.S. Cities, October 2003—September 2004. MMWR. 2005;54:601–605.
Schumann C, Kahn D, Broaddus M, et al. Implementing a standardized social networks testing strategy in a low HIV prevalence jurisdiction. AIDS Behav. 2019;23:41–47.
World Health Organization. WHO Recommends Social Network-Based HIV Testing Approaches for Key Populations as Part of Partner Services Package: Policy Brief. 2019. World Health Organization. Available at: https://apps.who.int/iris/handle/10665/329964 . Accessed March 22, 2020.
Walsh JL. Applying the information-motivation-behavioral skills model to understand PrEP intentions and use among men who have sex with men. AIDS Behav. 2019;23:1904–1916.
Mannheimer S, Hirsch-Moverman Y, Franks J, et al. Factors associated with sex-related pre-exposure prophylaxis Adherence among men who have sex with men in New York city in HPTN 067. J Acquir Immune Defic Syndr. 2019;80:551–558.
Dubov A, Altice FL, Fraenkel L. An information-motivation-behavioral skills model of PrEP uptake. AIDS Behav. 2018;22:3603–3616.
Liu A, Coleman K, Bojan K, et al. Developing a mobile App (LYNX) to support linkage to HIV/sexually transmitted infection testing and pre-exposure prophylaxis for young men who have sex with men: protocol for a randomized controlled trial. JMIR Res Protoc. 2019;8:e10659.
Whiteley L, Mena L, Craker LK, et al. Creating a theoretically grounded gaming App to increase adherence to pre-exposure prophylaxis: lessons from the development of the viral combat mobile phone game. JMIR Serious Games 2019;7:e11861.
Patel VV, Ginsburg Z, Golub SA, et al. Empowering with PrEP (E-PrEP), a peer-led social media-based intervention to facilitate HIV preexposure prophylaxis Adoption among young black and Latinx gay and bisexual men: protocol for a cluster randomized controlled trial. JMIR Res Protoc. 2018;7:e11375.
Flash CA, Frost ELT, Giordano TP, et al. HIV pre-exposure prophylaxis program implementation using intervention mapping. Am J Prev Med. 2018;54:519–529.
Centers for Disease Control and Prevention. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR. 2008;57:1–63.
Rothenberg R, Kimbrough L, Lewis-Hardy R, et al. Social network methods for endemic foci of syphilis: a pilot project. Sex Transm Dis. 2000;27:12–18.
Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
Rollnick S, Miller WR, Butler C. Motivational Interviewing in Health Care: Helping Patients Change Behavior. New York, NY: Guilford Press; 2008.
Safren S, Gonzalez J, Soroudi N. Coping with Chronic Illness: A Cognitive-Behavioral Approach for Adherence and Depression Therapist Guide. New York, NY: Oxford University Press; 2007.
Safren SA, Otto MW, Worth JL. Life-steps: Applying cognitive behavioral therapy to HIV medication adherence. Cogn Behav Pract. 1999;6:332–341.
Safren SA, Otto MW, Worth JL, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 2001;39:1151–1162.
Derogatis L, Spencer P. Brief Symptom Inventory: BSI. 1993. Upper Saddle River, NJ: Pearson.
Khanna AS, Michaels S, Skaathun B, et al. Preexposure prophylaxis Awareness and use in a population-based sample of young black men who have sex with men. JAMA Intern Med. 2016;176:136–138.
Napper LE, Fisher DG, Reynolds GL. Development of the perceived risk of HIV scale. AIDS Behav. 2012;16:1075–1083.
R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2018. Available at: https://www.R-project.org/ . Accessed December 29, 2018.
Hess KL, Hu X, Lansky A, et al. Lifetime risk of a diagnosis of HIV infection in the United States. Ann Epidemiol. 2017;27:238–243.
Bush S, Magnuson D, Rawlings MK, et al. Racial Characteristics of FTC/TDF for Pre-exposure Prophylaxis (PrEP) Users in the US. Boston, MA: ASM Microbe/ICAAC; 2016.
Ojikutu BO, Bogart LM, Higgins-Biddle M, et al. Facilitators and barriers to pre-exposure prophylaxis (PrEP) use among black individuals in the United States: results from the National survey on HIV in the black community (NSHBC). AIDS Behav. 2018;22:3576–3587.
Cahill S, Taylor SW, Elsesser SA, et al. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care. 2017;29:1351–1358.
Eaton LA, Driffin DD, Kegler C, et al. The role of stigma and medical mistrust in the routine health care engagement of black men who have sex with men. Am J Public Health. 2015;105:e75–82.
Clement ME, Johnston BE, Eagle C, et al. Advancing the HIV pre-exposure prophylaxis Continuum: a collaboration between a public health department and a federally qualified health center in the southern United States. AIDS Patient Care STDS. 2019;33:366–371.
Teixeira da Silva D, Bouris A, Voisin D, et al. Social networks moderate the syndemic effect of psychosocial and structural factors on HIV risk among young black transgender women and men who have sex with men. AIDS Behav. 2019:24:192–205.
Eaton LA, Driffin DD, Bauermeister J, et al. Minimal awareness and stalled uptake of pre-exposure prophylaxis (PrEP) among at risk, HIV-negative, black men who have sex with men. AIDS Patient Care STDS. 2015;29:423–429.
Whitfield THF, Parsons JT, Rendina HJ. Rates of pre-exposure prophylaxis use and discontinuation among a large U.S. National sample of sexual minority men and Adolescents. Arch Sex Behav. 2020;49:103–112.
Morgan E, Moran K, Ryan DT, et al. Threefold increase in PrEP uptake over time with high adherence among young men who have sex with men in Chicago. AIDS Behav. 2018;22:3637–3644.
Flash CA, Adegboyega OO, Yu X, et al. Correlates of linkage to HIV preexposure prophylaxis Among HIV-testing clients. J Acquir Immune Defic Syndr. 2018;77:365–372.
Pathela P, Jamison K, Blank S, et al. The HIV pre-exposure prophylaxis (PrEP) cascade at NYC sexual health clinics: Navigation is the key to uptake. J Acquir Immune Defic Syndr. 2020;83:357–364.
Khosropour CM, Backus KV, Means AR, et al. A pharmacist-led, same-day, HIV pre-exposure prophylaxis initiation program to increase PrEP uptake and decrease time to PrEP initiation. AIDS Patient Care St. 2020;34:1–6.
Kamis KF, Marx GE, Scott KA, et al. Same-day HIV pre-exposure prophylaxis (PrEP) initiation during drop-in sexually transmitted diseases clinic appointments is a highly acceptable, feasible, and safe model that engages individuals at risk for HIV into PrEP care. Open Forum Infect Dis. 2019;6:ofz310.
Rowan S, Patel R, Schneider J, et al. Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention. Lancet HIV. 2020:S2352-3018(20)30256-3. doi: 10.1016/S2352-3018(20)30256-3 [epub ahead of print].
doi: 10.1016/S2352-3018(20)30256-3
Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.
Glasgow RE, Green LW, Taylor MV, et al. An evidence integration triangle for aligning science with policy and practice. Am J Prev Med. 2012;42:646–654.
Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89:1322–1327.
Rusie LK, Orengo C, Burrell D, et al. Preexposure prophylaxis initiation and retention in care over 5 Years, 2012-2017: are quarterly visits too much? Clin Infect Dis. 2018;67:283–287.
Sitapati AM, Limneos J, Bonet-Vazquez M, et al. Retention: building a patient-centered medical home in HIV primary care through PUFF (Patients Unable to Follow-up Found). J Health Care Poor Underserved. 2012;23(3 suppl):81–95.
Corado K, Jain S, Morris S, et al. Randomized trial of a health coaching intervention to enhance retention in care: California collaborative treatment group 594. AIDS Behav. 2018;22:2698–2710.
Hidalgo J, Coombs E, Cobbs WO, et al. Roles and challenges of outreach workers in HIV clinical and support programs serving young racial/ethnic minority men who have sex with men. AIDS Patient Care STDS. 2011;25(suppl 1):S15–S22.

Auteurs

Daniel Teixeira da Silva (D)

Department of Combined Internal Medicine and Pediatrics, University of Chicago, Chicago, IL.
Department of Medicine, University of Chicago, Chicago, IL.

Alida Bouris (A)

School of Social Service Administration, University of Chicago, Chicago, IL.
Chicago Center for HIV Elimination, Chicago, IL.

Arthi Ramachandran (A)

Chicago Center for HIV Elimination, Chicago, IL.

Olivia Blocker (O)

Chicago Center for HIV Elimination, Chicago, IL.

Billy Davis (B)

Chicago Center for HIV Elimination, Chicago, IL.

James Harris (J)

Chicago Center for HIV Elimination, Chicago, IL.

Maria Pyra (M)

Chicago Center for HIV Elimination, Chicago, IL.
Howard Brown Health, Chicago, IL.

Laura K Rusie (LK)

Chicago Center for HIV Elimination, Chicago, IL.

Russell Brewer (R)

Department of Medicine, University of Chicago, Chicago, IL.
Chicago Center for HIV Elimination, Chicago, IL.

Jade Pagkas-Bather (J)

Department of Medicine, University of Chicago, Chicago, IL.
Chicago Center for HIV Elimination, Chicago, IL.
Howard Brown Health, Chicago, IL.

Anna Hotton (A)

Chicago Center for HIV Elimination, Chicago, IL.

Jessica P Ridgway (JP)

Department of Medicine, University of Chicago, Chicago, IL.
Chicago Center for HIV Elimination, Chicago, IL.

Moira McNulty (M)

Department of Medicine, University of Chicago, Chicago, IL.
Chicago Center for HIV Elimination, Chicago, IL.

Ramona Bhatia (R)

University of Illinois at Chicago, Chicago, IL; and.

John A Schneider (JA)

Department of Medicine, University of Chicago, Chicago, IL.
Chicago Center for HIV Elimination, Chicago, IL.
Howard Brown Health, Chicago, IL.
Department of Public Health Sciences, University of Chicago, Chicago, IL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH